Chemoinformaics analysis of ANTHRONE, 1,8-DIHYDROXY-3-METHOXY-6-METHYL-
| Molecular Weight | 270.284 | nRot | 1 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 16 |
| Exact Molecular Weight | 270.089 | nRing | 3 |
| Solubility: LogS | -3.539 | nHRing | 0 |
| Solubility: LogP | 4.347 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 39.2631 |
| nHD | 2 | BPOL | 16.6489 |
| QED | 0.592 |
| Synth | 2.443 |
| Natural Product Likeliness | 0.845 |
| NR-PPAR-gamma | 0.978 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.012 |
| HIA | 0.011 |
| CACO-2 | -5.055 |
| MDCK | 0.0000074 |
| BBB | 0.009 |
| PPB | 0.973113 |
| VDSS | 0.558 |
| FU | 0.0381867 |
| CYP1A2-inh | 0.985 |
| CYP1A2-sub | 0.904 |
| CYP2c19-inh | 0.335 |
| CYP2c19-sub | 0.071 |
| CYP2c9-inh | 0.615 |
| CYP2c9-sub | 0.878 |
| CYP2d6-inh | 0.631 |
| CYP2d6-sub | 0.792 |
| CYP3a4-inh | 0.172 |
| CYP3a4-sub | 0.124 |
| CL | 9.415 |
| T12 | 0.715 |
| hERG | 0.024 |
| Ames | 0.62 |
| ROA | 0.39 |
| SkinSen | 0.949 |
| Carcinogencity | 0.08 |
| EI | 0.952 |
| Respiratory | 0.823 |
| NR-Aromatase | 0.071 |
| Antiviral | Yes |
| Prediction | 0.759063 |